CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marston, E. L.
Right arrow Articles by Sampson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marston, E. L.
Right arrow Articles by Sampson, J.
Clinical and Diagnostic Laboratory Immunology, March 2002, p. 446-452, Vol. 9, No. 2
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.2.446-452.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Newly Characterized Species-Specific Immunogenic Chlamydophila pneumoniae Peptide Reactive with Murine Monoclonal and Human Serum Antibodies

Eric L. Marston,1* Andrea V. James,1 J. Todd Parker,2 John C. Hart,2 Teresa M. Brown,2 Trudy O. Messmer,1 Danny L. Jue,2 Carolyn M. Black,2 George M. Carlone,1 Edwin W. Ades,1 and Jacquelyn Sampson1

Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases,1 Scientific Resources Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia 303332

Received 22 August 2001/ Returned for modification 30 October 2001/ Accepted 12 December 2001

A monoclonal antibody (MAb) directed against an unknown Chlamydophila pneumoniae epitope has been characterized, and the respective peptide mimotope has been identified. A murine MAb specific for C. pneumoniae was used to select peptides from phage display libraries. The peptides identified from the phage display library clones reacted specifically with the respective target murine MAb and with human sera previously identified as having antibody titers to C. pneumoniae. The selected peptide mimotope sequences tended to be composed of charged residues surrounding a core of hydrophobic residues. The peptide with the best binding could inhibit >95% of binding to the MAb, suggesting that the selected peptide binds the paratope of the respective MAb. The peptide reacted with human sera previously determined by microimmunofluorescence to have anti-C. pneumoniae antibodies. The peptide was competitively competed with the MAb against Renografin-purified, sonicated C. pneumoniae in an enzyme-linked immunosorbent assay and with whole-cell C. pneumoniae in an indirect fluorescence assay format, demonstrating its potential utility in the development of diagnostics. The use of this novel peptide may allow investigators to establish standardized assays free from cross-reactive Chlamydia trachomatis and Chlamydophila psittaci epitopes and immunoreactivity.


* Corresponding author. Mailing address: Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop G-05, Atlanta, GA 30333. Phone: (404) 639-3653. Fax: (404) 639-4043. E-mail: EMARSTON{at}CDC.GOV.


Clinical and Diagnostic Laboratory Immunology, March 2002, p. 446-452, Vol. 9, No. 2
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.2.446-452.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.